Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Diago EB"'
Autor:
Diago, EB, Perez-Perez, J, Lasaosa, SS, Alebesque, AV, Martinez-Horta, S, Kulisevsky, J, del Val, JL
Publikováno v:
EUROPEAN JOURNAL OF NEUROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background and purposeCardiovascular events are a major cause of early death in the Huntington's disease (HD) population. Dysautonomia as well as deterioration of circadian rhythms can be detected early in the disease progression and can have profoun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::71f19802312cc7ecc23e9d4f9867c9ba
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3542
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3542
Publikováno v:
PARKINSONISM & RELATED DISORDERS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Introduction: Sleep and circadian rhythm disturbances are common in patients with neurodegenerative diseases such as Huntington's disease (HD). The aim of this study was to evaluate variability in circadian blood pressure (BP) to determine the associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::aa6003bbc8b75ccecffddbecccbb1f0c
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6067
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6067
Autor:
Pérez-Pérez J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain.; Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., García-López S; Medical Department, Roche Pharma, Madrid, Spain., Valle TF; Department of Neurology, University Hospital Cruces, Neurodegenerative Disease Group Health Research Institute of Bizkaia (BioBizkaia), Neuroscience Department University of the Basque Country, Leioa, Spain., Painous C; Parkinson and Movement Disorders Unit, Neurology Service, Hospital Clínic Universitari, Barcelona, Spain., Querol-Pascual MR; Department of Neurology, Hospital de Badajoz, Badajoz, Spain., Ruiz PJG; Movement Disorders Unit, Department of Neurology, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Diago EB; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Saragossa, Spain.; Research Group of Movement Disorders and Headache (GIIS070), Instituto de Investigación Sanitaria de Aragón (IIS-Aragón), Zaragozaa, Spain., Cubo Delgado E; Hospital Universitario de Burgos, University of Burgos, Burgos, Spain., Pastor BV; Servicio Neurología, Hospital Universitari Son Espases, Palma, Spain., Villaplana MCP; Hospital Universitario La Fe de Valencia, Valencia, Spain., Santana IM; Unidad de Trastornos del Movimiento, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Blázquez Estrada M; Hospital Universitario Central de Asturias, Asturias, Spain., Garride MC; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Álvarez C; Medical Department, Roche Pharma, Madrid, Spain., Maurino J; Medical Department, Roche Pharma, Madrid, Spain., de Prado A; Real World Evidence, IQVIA Information S.A, Madrid, Spain., López-Sendón JL; Department of Neurology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. jlsendonmoreno@salud.madrid.org.
Publikováno v:
Neurology and therapy [Neurol Ther] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.
Autor:
Pérez-Pérez J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain.; Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., García-López S; Medical Department, Roche Pharma, Madrid, Spain., Valle TF; Department of Neurology, University Hospital Cruces, Neurodegenerative Disease Group Health Research Institute of Bizkaia (BioBizkaia), Neuroscience Department University of the Basque Country, Leioa, Spain., Painous C; Parkinson and Movement Disorders Unit, Neurology Service, Hospital Clínic Universitari, Barcelona, Spain., Querol-Pascual MR; Department of Neurology, Hospital de Badajoz, Badajoz, Spain., Ruiz PJG; Movement Disorders Unit, Department of Neurology, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Diago EB; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Saragossa, Spain.; Research Group of Movement Disorders and Headache (GIIS070), Instituto de Investigación Sanitaria de Aragón (IIS-Aragón), Zaragozaa, Spain., Cubo Delgado E; Hospital Universitario de Burgos, University of Burgos, Burgos, Spain., Pastor BV; Servicio Neurología, Hospital Universitari Son Espases, Palma, Spain., Villaplana MCP; Hospital Universitario La Fe de Valencia, Valencia, Spain., Santana IM; Unidad de Trastornos del Movimiento, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Blázquez Estrada M; Hospital Universitario Central de Asturias, Asturias, Spain., Garride MC; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Álvarez C; Medical Department, Roche Pharma, Madrid, Spain., Maurino J; Medical Department, Roche Pharma, Madrid, Spain., de Prado A; Real World Evidence, IQVIA Information S.A, Madrid, Spain., López-Sendón JL; Department of Neurology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. jlsendonmoreno@salud.madrid.org.
Publikováno v:
Neurology and therapy [Neurol Ther] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.
Autor:
Diago EB; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Research group of Movement Disorders and Headache (GIIS070), Aragon Institute of Health Sciences, Zaragoza, Spain., Martínez-Horta S; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain., Lasaosa SS; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Research group of Movement Disorders and Headache (GIIS070), Aragon Institute of Health Sciences, Zaragoza, Spain., Alebesque AV; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Research group of Movement Disorders and Headache (GIIS070), Aragon Institute of Health Sciences, Zaragoza, Spain., Pérez-Pérez J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain., Kulisevsky J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain., Del Val JL; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Research group of Movement Disorders and Headache (GIIS070), Aragon Institute of Health Sciences, Zaragoza, Spain.
Publikováno v:
Journal of Huntington's disease [J Huntingtons Dis] 2018; Vol. 7 (2), pp. 193-198.
Autor:
Lasaosa SS; Departments of Neurology., Diago EB; Departments of Neurology., Calzada JN; Internal Medicine, Clinical University Hospital 'Lozano Blesa,' Zaragoza, Spain., Benito AV; Departments of Neurology.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2017 Jun 01; Vol. 18 (6), pp. 1161-1167.